Evidence map›Paper›PMID 25466901›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2015

Genetic deletion of TNFR2 augments inflammatory response and blunts satellite-cell-mediated recovery response in a hind limb ischemia model.

Sharath P Sasi, Layla Rahimi, Xinhua Yan, Marcy Silver, Gangjian Qin, Douglas W Losordo, Raj Kishore, David A Goukassian

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Sharath P SasiCardiovascular Research Center, GeneSys Research Institute, Boston, Massachusetts, USA;
Layla RahimiCardiovascular Research Center, GeneSys Research Institute, Boston, Massachusetts, USA;
Xinhua YanCardiovascular Research Center, GeneSys Research Institute, Boston, Massachusetts, USA; Tufts University School of Medicine, Boston, Massachusetts, USA;
Marcy SilverCardiovascular Research Center, GeneSys Research Institute, Boston, Massachusetts, USA;
Gangjian QinFeinberg Cardiovascular Institute, Feinberg School of Medicine Northwestern University, Chicago, Illinois, USA; and.
Douglas W LosordoFeinberg Cardiovascular Institute, Feinberg School of Medicine Northwestern University, Chicago, Illinois, USA; and.
Raj KishoreCenter for Translational Medicine, Temple University School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
David A GoukassianCardiovascular Research Center, GeneSys Research Institute, Boston, Massachusetts, USA; Tufts University School of Medicine, Boston, Massachusetts, USA; david.goukassian@tufts.edu.
Genesys (United States) · USNorthwestern University · USCardiovascular Research Center · BRTemple University · US

Funding

TNF mRNA stability and restenosisR01HL091983 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KISHORE, RAJ · 2009 to 2022
$5.3M
Neuregulin1 Alleviation of the "On-Target" Cardiotoxicity Caused by Inhibition ofR21HL106098 · NHLBI · GENESYS RESEARCH INSTITUTE, INC. · PI YAN, XINHUA · 2012 to 2013
$450k
NHLBI NIH HHS HL091983NHLBI NIH HHS HL106098NHLBI NIH HHS R01 HL091983NHLBI NIH HHS R21 HL106098NIA NIH HHS R21-AG02677
6 · The paper itself

Abstract

We have previously shown that TNF-tumor necrosis factor receptor-2/p75 (TNFR2/p75) signaling plays a critical role in ischemia-induced neovascularization in skeletal muscle and heart tissues. To determine the role of TNF-TNFR2/p75 signaling in ischemia-induced inflammation and muscle regeneration, we subjected wild-type (WT) and TNFR2/p75 knockout (p75KO) mice to hind limb ischemia (HLI) surgery. Ischemia induced significant and long-lasting inflammation associated with considerable decrease in satellite-cell activation in p75KO muscle tissue up to 10 d after HLI surgery. To determine the possible additive negative roles of tissue aging and the absence of TNFR2/p75, either in the tissue or in the bone marrow (BM), we generated 2 chimeric BM transplantation (BMT) models where both young green fluorescent protein (GFP)-positive p75KO and WT BM-derived cells were transplanted into adult p75KO mice. HLI surgery was performed 1 mo after BMT, after confirming complete engraftment of the recipient BM with GFP donor cells. In adult p75KO with the WT-BMT, proliferative (Ki67(+)) cells were detected only by d 28 and were exclusively GFP(+), suggesting significantly delayed contribution of young WT-BM cell to adult p75KO ischemic tissue recovery. No GFP(+) young p75KO BM cells survived in adult p75KO tissue, signifying the additive negative roles of tissue aging combined with decreased/absent TNFR2/p75 signaling in postischemic recovery.

Indexed as

AnimalsApoptosisBone Marrow TransplantationCell ProliferationDisease Models, AnimalGreen Fluorescent ProteinsHindlimbInflammationIschemiaMacrophagesMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicNeovascularization, PhysiologicGreen Fluorescent ProteinsReceptors, Tumor Necrosis Factor, Type IIRecombinant Proteinsapoptosismuscle regenerationproliferationTNF-TNFR2/p75 signaling

Identifiers

PMID25466901
PMCPMC4396611
OpenAlexW2071380055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.